Image Credit: Wikipedia Announcement In a recent meeting, the FDA stressed the importance of future planning and planned to add a ‘precheck’ step in the drug approval procedure to achieve pinpoint accuracy in drug selection. This discussion was led by the concern and the worst ...
Image Credit: www.bms.com Announcement The Evotec SE, honouring its smart neuroscience collaboration, has announced that the company has received the milestone (profit) payment worth US$25M from Bristol Myers Squibb on its scientific progress gained within this partnership. The payment wil...
Announcement In Lisbon’s Alfama district, in Chicago, the retiree calculated his specific budget as $350 for groceries, $55 healthcare supplement and $1,120 for rent and his US insurance is worth $847 monthly. The ‘free healthcare’ is definitely real, but not uniform or true to t...
Announcement The uniqueness of gene therapy for Huntington’s disease’s pivotal results is a new ray of hope for patients disappointed in the past few years. Though one expert is concerned about the communication of the results, which are building false expectations. It is said that few...
Image Credit: www.gehealthcare.in GEHC’s AI partnership to turn into an opportunity or just an experiment GE Healthcare has recently partnered with Duke Health and Queen’s Health Systems to provide strong support to its newest AI-fueled hospital operations software. The software focu...
Image Credit: Clinical Trial Arena Announcement The Thermo Fisher Scientific’s PPD™ clinical research business holder and the global leader in delivering science has introduced its innovative clinical trial carbon calculator. The innovative clinical trial carbon calculator is enginee...
Image Credit: CCO Announcement Cairn Surgical Inc., a leading creative medical technology company, actively participates in making breast cancer surgery more accurate, informed that the multicentre study publicly published in the November issue of the Annals of Surgical Oncology elaborated...
Image Credit: Contract Pharma Announcement Ventus Therapeutics, a leading clinical-level biopharmaceutical company upgrading two phase 2 small-molecule programs for inflammatory, neurological and immunological disorders, has entered a long-term partnership with Genentech. A Genentech is a ...
Image Credit: Quantzig Announcement Since AI has entered the global market across all sectors, it has initially been met with hesitation among biopharma companies. Today, AI is transforming the traditional methods and shifting the nature of leadership at every stage in biopharma. The execu...
Announcement The Aletheia Capital Endeavours (ACE), a leading firm, has introduced the repIntel solution. It’s an accurate field-smart platform engineered to fill a part of the gap in healthcare’s failure in lifesaving, precious therapies that should’ve reached the patient...
